AcquisitionOther
Cerevel Therapeutics Holdings, Inc. acquired Cerevel Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Cerevel Therapeutics Holdings, Inc. -> Cerevel Therapeutics · $0.19
We are excited to welcome the talented Cerevel team to AbbVie. There are multiple programs in Cerevels pipeline across several neurological and psychiatric conditions such as schizophrenia, Parkinsons disease and mood disorders, where there continues to be
Open source record (SEC) ↗